DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (24)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Campath side effects in male

Reported by a consumer/non-health professional from France on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend



Possible Campath side effects in male

Reported by a consumer/non-health professional from France on 2012-08-17

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Abdominal Pain Lower, Prostatitis, Adenovirus Infection, Dysuria, Cystitis Haemorrhagic, Pollakiuria, Human Polyomavirus Infection, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Valganciclovir; Vfend; Folic Acid; Bactrim



Possible Campath side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva



Possible Campath side effects in female

Reported by a physician from Germany on 2012-04-16

Patient: female, weighing 69.7 kg (153.3 pounds)

Reactions: Cardiac Failure, C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-01-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Levothyroxine Sodium; Ramipril Plus



Possible Campath side effects in male

Reported by a individual with unspecified qualification from United States on 2012-03-27

Patient: male, weighing 119.0 kg (261.8 pounds)

Reactions: Nasopharyngitis, Dyspnoea, Hypotension, Pulmonary Embolism, Acidosis, Oropharyngeal Pain, Pyrexia, Cardio-Respiratory Arrest, Hypoxia, Acute Respiratory Distress Syndrome, Septic Shock, Respiratory Syncytial Virus Test Positive, Lung Infiltration, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 360 mg

Cyclophosphamide
    Dosage: 1404 mg

Pentostatin
    Dosage: 9.36 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 878 mg

Other drugs received by patient: Bactrim DS; Acyclovir



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-20

Patient: female, weighing 69.7 kg (153.3 pounds)

Reactions: C-Reactive Protein Increased, Cardiac Failure, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-01-09
    End date: 2012-02-20

Other drugs received by patient: Levothyroxine Sodium; Acyclovir; Ramipril Plus; Cotrim Forte EU RHO; Ciprofloxacin



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-12

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-01-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-02-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus; Levothyroxine Sodium



Possible Campath side effects in female

Reported by a physician from Germany on 2012-03-08

Patient: female, weighing 160.0 kg (352.0 pounds)

Reactions: C-Reactive Protein Increased, Pleural Effusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-01-29

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-09
    End date: 2012-02-23

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2012-02-09
    End date: 2012-02-20

Other drugs received by patient: Ciprofloxacin; Levothyroxine Sodium; Cotrim Forte EU RHO; Acyclovir; Ramipril Plus



Possible Campath side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient: 54 year old male, weighing 119.0 kg (261.8 pounds)

Reactions: Nasopharyngitis, Dyspnoea, Oropharyngeal Pain, Pyrexia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acyclovir Sodium
    Dosage: 100 mg mwf cycle 1, then 878 d1 cycle 2-6
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-03-14
    End date: 2011-08-02

Campath
    Dosage: 30 mg, tiw x 4 weeks, subcutaneous
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-31
    End date: 2011-11-25

Cytoxan
    Dosage: 1404 mg on d1 c1-6, wks 1, 5, 9, 13, 17 and 21, intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-03-14
    End date: 2011-08-02

Nipent
    Dosage: 9.36 mg on day 1 c1-6, intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-03-14
    End date: 2011-08-02

Other drugs received by patient: Bactrim DS; Acyclovir



Possible Campath side effects in female

Reported by a physician from Germany on 2012-02-29

Patient: female, weighing 79.0 kg (173.8 pounds)

Reactions: Dyspnoea, Lung Disorder, Pyrexia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, once daily every 15 days
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-12-09
    End date: 2011-12-23

Dexamethasone
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Neulasta
    Dosage: unk
    Indication: Neutropenia

Other drugs received by patient: Fluoxetine; Crestor; Vitamin D; Acyclovir; Nexium; Levothyroxine Sodium; Pentacarinat



Possible Campath side effects in male

Reported by a physician from United States on 2012-02-21

Patient: male, weighing 119.0 kg (261.8 pounds)

Reactions: Dyspnoea, Nasopharyngitis, Oropharyngeal Pain, Pyrexia, Hypoxia, Respiratory Syncytial Virus Test Positive, Lung Infiltration, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 360 mg

Cyclophosphamide
    Dosage: 1404 mg

Pentostatin
    Dosage: 9.36 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 878 mg

Other drugs received by patient: Bactrim DS; Acyclovir



Possible Campath side effects in male

Reported by a consumer/non-health professional from Germany on 2012-02-15

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-12-09

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-11-30

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-10-12
    End date: 2011-12-09

Other drugs received by patient: Tamsulosin HCL; Voriconazole; Cotrim; Valcyte; Metoclopramide



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-08

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-12-09

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-11-30

Neulasta
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-10-12
    End date: 2011-12-09

Other drugs received by patient: Cotrim; Valcyte; Voriconazole; Metoclopramide; Tamsulosin HCL



Possible Campath side effects in male

Reported by a physician from France on 2012-01-30

Patient: male

Reactions: Vomiting, Chills, Rash Erythematous, Pyrexia, Disease Progression, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2010-05-03
    End date: 2010-05-03

Campath
    Dosage: unk
    Start date: 2010-06-14
    End date: 2010-06-14

Campath
    Dosage: unk
    Start date: 2010-06-07
    End date: 2010-06-07



Possible Campath side effects in

Reported by a physician from Netherlands on 2012-01-09

Patient:

Reactions: Fatigue, General Physical Health Deterioration, Pyrexia, Decreased Appetite

Drug(s) suspected as cause:
Campath
    Dosage: unk, 3 to 30 mg
    Indication: Hepatosplenic T-Cell Lymphoma

Campath
    Dosage: 30 mg unk, 11 doses administered



Possible Campath side effects in 64 year old male

Reported by a physician from Italy on 2012-01-03

Patient: 64 year old male

Reactions: Visceral Leishmaniasis, Pancytopenia, Pyrexia, Splenomegaly

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath



Possible Campath side effects in male

Reported by a physician from Germany on 2011-12-20

Patient: male

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-12-09

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-12
    End date: 2011-11-30

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-10-12
    End date: 2011-12-09

Other drugs received by patient: Metoclopramide; Valcyte; Voriconazole; Cotrim; Tamsulosin HCL



Possible Campath side effects in female

Reported by a physician from Germany on 2011-12-15

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 unk, unk
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-16

Dexamethasone
    Dosage: 40 unk, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-10

Pegfilgrastim
    Dosage: 6 unk, unk
    Indication: Neutropenia
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acyclovir; Levofloxacin; Acetylcysteine



Possible Campath side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07

Patient: 61 year old male

Reactions: Cardiac Failure, Dehydration, Skin Lesion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath



Possible Campath side effects in female

Reported by a physician from Germany on 2011-11-28

Patient: female, weighing 71.0 kg (156.2 pounds)

Reactions: C-Reactive Protein Increased, General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 unk, unk
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-16

Dexamethasone
    Dosage: 40 unk, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-11-07
    End date: 2011-11-10

Pegfilgrastim
    Dosage: 6 unk, unk
    Indication: Neutropenia
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Levofloxacin; Acetylcysteine; Acyclovir; Cotrim; Pantoprazole Sodium



Possible Campath side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-02

Patient: 62 year old male

Reactions: Epstein-Barr Virus Infection, Dyspnoea, Dysphagia, Hypoxia, Epstein-Barr Virus Associated Lymphoproliferative Disorder, Pyrexia, Oropharyngeal Pain, Sinus Congestion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Indication: Prophylaxis Against Graft Versus Host Disease

Campath

Fludara
    Indication: Prophylaxis Against Graft Versus Host Disease

Fludara

Other drugs received by patient: Melphalan Hydrochloride; Melphalan Hydrochloride; Cyclosporine



Possible Campath side effects in 42 year old

Reported by a physician from Germany on 2011-11-01

Patient: 42 year old

Reactions: Death, Herpes Simplex, Sepsis, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Busulfan; Fluconazole; Acyclovir; Trimethoprim; Basiliximab; Anti-Thymocyte Globulin NOS; Sulphamethoxazole; Etanercept; Daclizumab; Methotrexate; Cyclophosphamide; Mycophenolate Mofetil; Cyclosporine



Possible Campath side effects in 62 year old male

Reported by a physician from United Kingdom on 2011-10-31

Patient: 62 year old male

Reactions: Epstein-Barr Virus Infection, Dysphagia, Dyspnoea, Hypoxia, Epstein-Barr Virus Associated Lymphoproliferative Disorder, Oropharyngeal Pain, Pyrexia, Sinus Congestion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 10 mg qd, days -1 to -3
    Indication: Stem Cell Transplant

Campath
    Indication: Refractory Anaemia

Fludara
    Dosage: unk
    Indication: Stem Cell Transplant

Fludara
    Indication: Refractory Anaemia

Melphalan Hydrochloride
    Dosage: unk
    Indication: Stem Cell Transplant

Melphalan Hydrochloride
    Indication: Refractory Anaemia

Other drugs received by patient: Cyclosporine



Possible Campath side effects in 42 year old

Reported by a physician from Germany on 2011-10-14

Patient: 42 year old

Reactions: Death, Herpes Simplex, Sepsis, Pyrexia

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Anti-Thymocyte Globulin NOS; Trimethoprim; Mycophenolate Mofetil; Etanercept; Basiliximab; Methotrexate; Acyclovir; Cyclosporine; Daclizumab; Sulphamethoxazole; Fluconazole; Cyclophosphamide; Busulfan

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017